Flexible labs, co-working space: Big Pharma is rethinking real estate

At an industry event Thursday, representatives from both Merck& Co. and Bristol-Myers Squibb stressed the importance of flexibility in real-estate assets.

Source: bizjournals.com Health Care:Biotechnology headlines - September 20, 2018 Category: Biotechnology Authors: Catherine Carlock Source Type: news